Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

8.0%

7 terminated/withdrawn out of 88 trials

Success Rate

87.9%

+1.3% vs industry average

Late-Stage Pipeline

42%

37 trials in Phase 3/4

Results Transparency

4 of 51 completed trials have results

Key Signals

17 recruiting4 with results

Enrollment Performance

Analytics

N/A

31(40.8%)

Phase 3

24(31.6%)

Phase 4

13(17.1%)

Phase 2

7(9.2%)

Phase 1

1(1.3%)

76Total

N/A(31)

Phase 3(24)

Phase 4(13)

Phase 2(7)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (88)

Showing 20 of 88 trials

NCT04381143Phase 4Active Not Recruiting

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Role: collaborator

NCT07784647Completed

A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol

Role: collaborator

NCT07569640Phase 3Recruiting

HFrEF Polypill in Sri Lanka RCT

Role: collaborator

NCT06819592Phase 3Recruiting

PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

Role: lead

NCT06471972Active Not Recruiting

Biomarkers After Out-of-hospital Cardiac Arrest- a STEPCARE Substudy

Role: collaborator

NCT05434325Completed

TESTING -ON Post-Trial ObservatioNal Cohort Study

Role: lead

NCT06763055Phase 3Recruiting

The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

Role: lead

NCT06352619Not ApplicableRecruiting

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial

Role: lead

NCT06352632Phase 3Recruiting

ACT-GLOBAL Adaptive Platform Trial for Stroke

Role: lead

NCT04157231Not ApplicableNot Yet Recruiting

Essential Acute Stroke Care in Low Resource Settings: a Pilot studY

Role: lead

NCT06278779Phase 4Recruiting

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression

Role: lead

NCT06594926Phase 2Recruiting

Working Out M0 Bipolar Androgen Therapy

Role: collaborator

NCT06058585Phase 3Recruiting

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Role: lead

NCT05468203Phase 3Terminated

PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care

Role: lead

NCT03969953Phase 3Completed

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

Role: lead

NCT05402657Not ApplicableCompleted

The RAFT ECT Study

Role: lead

NCT05458323Not ApplicableRecruiting

Cognitive Level Enhancement Through Vision Exams and Refraction

Role: collaborator

NCT06321419Not ApplicableRecruiting

Effects of Advanced Trauma Life Support® on Adult Trauma Patient Outcomes

Role: collaborator

NCT06409364Phase 2Recruiting

FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage

Role: lead

NCT04389827Completed

Global Kidney Patient Trials Network

Role: lead